Presentation is loading. Please wait.

Presentation is loading. Please wait.

You are what you exhale Every time that we exhale We release volatile compounds 1.

Similar presentations


Presentation on theme: "You are what you exhale Every time that we exhale We release volatile compounds 1."— Presentation transcript:

1 You are what you exhale Every time that we exhale We release volatile compounds 1

2 The answer is… We are a company that develops medical devices to analyse breath and diagnose “Tuberculosis” and “Aspergillosis” simultaneously! CEO Financials Marketing Operations R&D Aiah KhatebDr. Evaldez KlumbysAaron Hernandez CidTania Sanchez MonroyLeonid Nichman 2

3 Why Tuberculosis and Aspergillosis? 7,982 cases of Tuberculosis were notified in the UK in 2013 Aspergillosis affects over 1,000,000 people Over 25,000 deaths are estimated every year 95 % of Tuberculosis occurred in developing countries Over 8,000,000 cases of Aspergillosis reported worldwide 12 % of Aspergillosis cases are related to tuberculosis Over 8,000,000 cases of Aspergillosis reported worldwide 12 % of Aspergillosis cases are related to tuberculosis 3

4 Market Segmentation USA 42% Asia 21% Germany 11% UK 9% Latin America 16% South Africa 1% Distribution of global market Roche 40% Beckman 10% Siemens 10% Abbott 10% Market share by companies 4

5 Market Segmentation other 5

6 Competitive advantage & SWOT analysis Detection in 1 min Non-invasive 96.7 % sensitivity 98.3 % specificity Portable Price £40 Price range £75-£1,500 least 12 hours Invasive 64.5% sensitivity 93.2% specificity Immobile Sputum Mask 6

7 Marketing plan 7

8 8 VIDEO HERE

9 Gold & carbon nanoparticles specific to volatile chemicals from Aspergillus and Tuberculosis Breath analysis with graphene & carbon nanoparticles Voltron 1.0 Carbon nanoparticles and graphene Inferred statistical model of the response Gas chromatography Mass spectrometry Chromatogram result SICKOK 9

10 Graphene sheet Linker molecule Binding chemical H A K D P 1.A graphene sheet array comprising of key molecules A, D, H, K, P for detection of TB and Aspergillosis. 2.A device comprising an array according to claim 1. 3.A device according to claim 2 wherein the device is a mask. IP strategy 10

11 Our story 11

12 Logistics Masks Manufacturing Electronics and plastics manufacturing and assembly Year 1Year 2Year 3Year 4Year 5 Storage and QC Local distributor 12

13 Roadmap (short term) 13

14 Roadmap (pipeline) 14

15 Loss & Profit 15 years £

16 16

17 Summary We ask for 2 M £ for 10% equity Turn over time 6 years 17

18 In Volatronics™ saving lives is as easy as breathing 18

19 Total costs 19

20 Q&A slides 20

21 Advertising plan 21

22 Scientists can analyse our breath They collect all the volatiles …and tell you how healthy are your lungs! 22

23 Now imagine what we can do… lung information piece of exhaled air 23

24 Product: Voltron 1.0 In 2014 we started to collect literature information about volatile biomarkers. First prototype of mask Validation with clinical trials at the National Center of Aspergillus in Southern Manchester, notified to the MHRA (Medicines and Healthcare products Regulatory Agency), fee £5,040 Conformity assessment for CE marking carried out by BSI Healthcare, fee £8,000 Licensing to Omega Diagnostic Ltd (Manufacture) Licensing to Avenzys Medical (Distributor) Full quality assurance audit by a notified body to ISO 13485:2003 24

25 Stakeholders Biotech company /R&D organization Biotech company R&D organization Sensor vendors & devolompers Pharmacceutic al companies 25

26 mask 26

27 Risk management 27

28 Strengths, Weakness, Opportunity & Threats Strengths: Key player in rapid detection kits market Unique and novel detection technique Backed by scientific authorities of the field Focus on product R&D in broadening horizontal applications Challenges Branding International markets Risks management Opportunities Solutions for different invasive diseases. Upgrading the current immobile analysis stations in hospitals and clinics to portable devices Become a self-distributor Large investment in R&D and patenting Customer’s health leads to growth in reputation and increase of clients Threats Competitive threat from companies with emerging technology 28

29 budget 29

30 budget 30

31 Human resources Aaron Hernandez Cid (CEO): Aaron is a true entrepreneur, and a co-founder of several start-ups (e.g. Cloudpaper), Starting in "Los Zetas Corp." Juarez, Mexico where he had the role of CEO and continuing to head Beltrán-Leyva Ltd. dealing mostly with oil. Aaron found out from the news about the severe breathing problems his corporation had caused, in fact after suffering from a personal family loss he've decided to start up a company which will provide cheap solutions for any breath detectable illnesses, he teamed up with Evaldez a young researcher and decided to start with fungus detection in lungs. Evaldez Klumbys (R & D): Young researcher, after finishing his PhD in Fungus research and lung deseases etc. he started to look for practical opportunities to make some money. He gained some work experience in the GSK where he has developed a special mask design for breath analysis. He travelled to several conferences where he met Aaaron during one of the Pitch for investment sessions. Evaldez was glad to take the role of R&D director in Volatronics. Aiah Khateb. (Marketing): M.Sc in Microbiology and Infectious Diseases at Calgary's Center of Antimicrobial Resistance, Canada. Winner of Canadian Microbiology Marketing Award, 2014, Victoria AMMI Canada. Has 2 years marketing experience from the Canadian innovation centre. Currently works on identifying novel Molecular Detection & Mechanisms of Antifungal Resistance in Aspergillus fumigatus as a researcher, at University of Manchester. Always felt like there is not enough exposure to the dangers and severity of illnesses related to fungus. As a leading researcher in this field Aiah felt obligated to join any company that will address fungus related illnesses and especially she was happy to take the marketing role as she is very passionate and motivated to rise awareness in this field. 31

32 Human resources Tania Sanchez Monroy. (Financials): Spending several years in TWAS (The Third World Academy of Sciences) grants committee as a judge and for another 2 years as an advisor in a Governmental “Business and Science” committee of Mexico. Tania has all the skills and networking needed to get the funds and investments and to keep the company profitable Specialities: Strategic Planning, Technology & Innovation Management, Materials science and biomechanics,, Team working, Health industry partnership projects. Leonid Nichman. (HR & Operations): M.Sc Chemistry and Materials science, had 5 years of experience of operations and logistics in a printing corporation. dealing with suppliers, processing orders and building the whole logistics chain. Leonid won the VentureOut prize of 2015 for his ideas for improvements of Graphene production lines. Leonid is a team player and an HR specialist with a long experience of managing and coordinating international and multidisciplinary teams at CERN. Leonid is a polyglot with a deep knowledge of Mandarin which facilitates the collaboration with our manufacturers in China. 32

33 Mr. Aaron Hernandez Cid CEO Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 A.Cid@volatronics.com Dr. Evaldez Klumbys Research & Development Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 E. Klumbys@volatronics.com Ms.Aiah Khateb Marketing & Advertising Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 A.khateb@volatronics.com Mr.Leonid Nichman HR & Operations Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 L. Nichman@volatronics.com Ms.Tania Sanchez Monroy Financials Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 T. Monroy@volatronics.com Mr. Aaron Hernandez Cid CEO Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 A.Cid@volatronics.com Dr. Evaldez Klumbys Research & Development Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 E. Klumbys@volatronics.com Ms.Aiah Khateb Marketing & Advertising Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 A.khateb@volatronics.com Mr.Leonid Nichman HR & Operations Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 L. Nichman@volatronics.com Ms.Tania Sanchez Monroy Financials Citylabs Nelson St, Manchester M13 9NQ Phone :0161 393 2288 Fax (203) 555-0101 T. Monroy@volatronics.com 33

34 Malaysian Plastics manufacturers association 34

35 Chip china SHAANXI LIFEGEN CO..LTD - biomems Shanghai Biochip Co. Ltd. No.151,Libing Rd.,Zhangjiang Hi-Tech Park,Pudong 201203 Shanghai ChinaTel.+86-21-51320288 35

36 Injection molding plastics Kenny Han / Manager(mobil:13061707408 , 18964821913) TEL:+86-21-52913487 FAX:+86-21-59907680 E-mail:webmaster@cnmoulding.com ADDRESS:NO1062,JiaXing ROAD, SHANGHAI,CHINA 36


Download ppt "You are what you exhale Every time that we exhale We release volatile compounds 1."

Similar presentations


Ads by Google